Progression of aortic valve sclerosis to aortic stenosis

American Journal of Cardiology

Volumn 91, Issue 1, 2003, Pages 99-101

  Faggiano, Pompilio ^a,b,c   Antonini Canterin, Francesco ^a,b   Erlicher, Andrea ^a,b   Romeo, Cristina ^a,b   Cervesato, Eugenio ^a,b   Pavan, Daniela ^a,b   Piazza, Rita ^a,b   Huang, Guoqian ^a,b   Nicolosi, Gian Luigi ^a,b  

^a S MARIA DEGLI ANGELI HOSPITAL   (Italy)

^b Ospedale di Bolzano   (Italy)

^c NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANALYTICAL PARAMETERS; AORTA ATHEROSCLEROSIS; AORTA STENOSIS; AORTA VALVE; AORTA VALVE DISEASE; ARTICLE; BLOOD REGURGITATION; CALCIFICATION; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; DEMOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; FLOW RATE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

AGED; AORTIC DISEASES; AORTIC VALVE STENOSIS; DISEASE PROGRESSION; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART VALVE DISEASES; HUMANS; MALE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0037219042     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)03011-4     Document Type: Article

References (14)

1. Lindroos M., Kupari M., Heikkila J., Tilvis R. Prevalence of aortic valve abnormalities in the elderly an echocardiographic study of a random population sample . J Am Coll Cardiol. 21:1993;1220-1225.
2. Stewart B.F., Siscovick D., Lind B.K., Gardin J.M., Gottdiener J.S., Smith V.E., Kitzman D., Otto C.M. Clinical factors associated with calcific aortic valve disease. J Am Coll Cardiol. 29:1997;630-634.
3. Otto C.M., Lind B.K., Kitzman D., Gersh B.J., Siscovick D. Association of aortic valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 341:1999;142-147.
4. Faggiano P., Aurigemma G.P., Rusconi C., Gaasch W.H. Progression of valvular aortic stenosis in adults literature review and clinical implications . Am Heart J. 132:1996;407-417.
5. Rosenhek R., Binder T., Porenta G., Lang I., Christ G., Schemper M., Maurer G., Baumgartner H. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med. 343:2000;611-617.
6. Antonini-Canterin F., Nicolosi G.L. Hemodynamic progression of aortic stenosis in asymptomatic patients. Ital Heart J. 3:(suppl):2002;478-485.
7. Otto C.M., Burwash I.G., Legget M.E., Munt B.I., Fujioka M., Healy N.L., Kraft C.D., Miyake-Hull C., Schwaegler R.G. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic and exercise predictors of outcome. Circulation. 95:1997;2262-2270.
8. Palta S, Pai AM, Gill KS, Pai RG. New insights into the progression of aortic stenosis. Implications for secondary prevention Circulation 2000;101:2497-2502.
9. Cohen J.L., Barooah B., Segal K.R., Batuman V. Two-dimensional echocardiographic findings in patients on hemodialysis for more than six months. Am J Cardiol. 60:1987;743-745.
10. Huting J. Progression of valvular sclerosis in end-stage renal disease treated by long-term peritoneal dialysis. Clin Cardiol. 15:1992;745-750.
11. Urena P., Malergue M.C., Goldfarb B., Prieur P., Guedon-Rapoud C., Petrover M. Evolutive aortic stenosis in hemodialysis patients analysis of risk factors . Nephrologie. 20:1999;217-225.
12. Pohle K., Maffert R., Ropers D., Moshage W., Stilianakis N., Daniel W.G., Achenvbach S. Progression of aortic valve calcification. Association with coronary atherosclerosis and cardiovascular risk factors. Circulation. 104:2001;1927-1932.
13. Shavelle D.M., Takasu J., Budoff M.J., Mao S.S., Zhao X., O'Brien K.D. HMG CoA reductase inhibitor (statin) and aortic valve calcium. Lancet. 359:2002;1125-1126.
14. Cosmi JE, Kort S, Tunick PA, Rosenzweig BP, Freedberg RS, Katz ES, Applebaum RM, Kronzon I. The risk of the development of aortic stenosis in patients with "benign" aortic valve thickening. Arch Intern Med 2002;162:2345-2347.